, Tracking Stock Market Picks
Enter Symbol:
Synovis Life Technologies, Inc. (SYNO) [hlAlert]

down 0.42 %

Synovis Life Technologies, Inc. (SYNO) downgraded to Sell by Feltl & Co.

Posted on: Wednesday,  Jan 11, 2012  12:25 PM ET by Feltl & Co.

Feltl & Co. rated Sell Synovis Life Technologies, Inc. (NASDAQ: SYNO) on 01/11/2012, when the stock price was $27.89.
Since then, Synovis Life Technologies, Inc. has gained 0.43% as of 02/14/2012's recent price of $28.01.
If you would have followed this Feltl & Co.'s recommendation on SYNO, you would have lost 0.42% of your investment in 34 days.

Synovis Life Technologies, Inc. is a diversified medical device company engaged in developing, manufacturing, marketing and selling implantable biomaterial products, devices for microsurgery and surgical tools. Its products serve an array of medical markets, including general surgery, bariatric, vascular, cardiac, thoracic, neurological and microsurgery. The Company is engaged in the development and manufacturing of implantable biomaterial products for use by surgeons in various procedures where reinforcing, reconstructing and repairing tissue and preventing leaks of air, blood or other body fluids. In January 2008, the Company announced that it had closed on the previously announced sale of substantially all of the assets of its interventional business to Heraeus Vadnais and related entities.

Feltl and Company's Research Department is focused on micro to small market capitalization companies that are not widely covered by other research firms. Our research universe is focused and organized around the sectors of Technology, HealthCare, and Leisure/Consumer. Feltl and Company holds its research department to very high standards, and strives to provide value- added investment ideas through sound fundamental analysis. Feltl and Company's Research Department includes six senior analysts and one associate analyst with many years of investment analysis experience. Although we are focused on, and committed to, companies in the Upper Midwest, our reach extends from coast to coast. About half of the companies we cover are headquartered outside our "backyard." Our analysts have significant industry experience and strive to know their companies inside and out. Through stringent analysis, they provide value by creating a disciplined application of company valuation, allowing our clients to make sound investment decisions.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/11/2012 12:25 PM Sell
as of 12/31/2012
1 Week   
1 Month   
3 Months   
1 YTD down  -0.43 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/13/2011 12:25 PM Hold
27.78 28.00
8/28/2008 9:25 AM Buy
23.17 27.50
9/4/2007 9:25 AM Buy
19.66 22.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy